Principal Financial Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $42.9K | Buy |
16,253
+4,832
| +42% | +$12.8K | ﹤0.01% | 2195 |
|
2025
Q1 | $34.4K | Sell |
11,421
-172
| -1% | -$518 | ﹤0.01% | 2134 |
|
2024
Q4 | $29.7K | Sell |
11,593
-920
| -7% | -$2.36K | ﹤0.01% | 2184 |
|
2024
Q3 | $46.5K | Sell |
12,513
-28,706
| -70% | -$107K | ﹤0.01% | 2182 |
|
2024
Q2 | $261K | Sell |
41,219
-32,247
| -44% | -$204K | ﹤0.01% | 2088 |
|
2024
Q1 | $395K | Sell |
73,466
-2,818
| -4% | -$15.1K | ﹤0.01% | 2035 |
|
2023
Q4 | $383K | Buy |
76,284
+64
| +0.1% | +$321 | ﹤0.01% | 2008 |
|
2023
Q3 | $129K | Buy |
76,220
+2,166
| +3% | +$3.66K | ﹤0.01% | 2241 |
|
2023
Q2 | $206K | Buy |
74,054
+9,246
| +14% | +$25.7K | ﹤0.01% | 2176 |
|
2023
Q1 | $118K | Sell |
64,808
-4,164
| -6% | -$7.58K | ﹤0.01% | 2279 |
|
2022
Q4 | $350K | Buy |
68,972
+11,801
| +21% | +$59.8K | ﹤0.01% | 2065 |
|
2022
Q3 | $285K | Buy |
57,171
+1,678
| +3% | +$8.37K | ﹤0.01% | 2094 |
|
2022
Q2 | $206K | Buy |
55,493
+9,925
| +22% | +$36.8K | ﹤0.01% | 2296 |
|
2022
Q1 | $256K | Sell |
45,568
-1,248
| -3% | -$7.01K | ﹤0.01% | 2279 |
|
2021
Q4 | $285K | Buy |
46,816
+25,163
| +116% | +$153K | ﹤0.01% | 2258 |
|
2021
Q3 | $211K | Sell |
21,653
-3,510
| -14% | -$34.2K | ﹤0.01% | 2417 |
|
2021
Q2 | $359K | Buy |
25,163
+1,173
| +5% | +$16.7K | ﹤0.01% | 2299 |
|
2021
Q1 | $570K | Buy |
23,990
+1,690
| +8% | +$40.2K | ﹤0.01% | 2124 |
|
2020
Q4 | $297K | Buy |
22,300
+2,284
| +11% | +$30.4K | ﹤0.01% | 2241 |
|
2020
Q3 | $139K | Sell |
20,016
-990
| -5% | -$6.88K | ﹤0.01% | 2246 |
|
2020
Q2 | $258K | Buy |
+21,006
| New | +$258K | ﹤0.01% | 2123 |
|